Hepatitis A virus and the origins of picornaviruses

Nature

Volumn 517, Issue 7532, 2015, Pages 85-88

  Wang, Xiangxi ^a   Ren, Jingshan ^b   Gao, Qiang ^a,c   Hu, Zhongyu ^d   Sun, Yao ^a   Li, Xuemei ^a   Rowlands, David J ^e   Yin, Weidong ^c   Wang, Junzhi ^d   Stuart, David I ^b,f   Rao, Zihe ^a,g,h   Fry, Elizabeth E ^b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Sinovac Biotech Co Ltd   (China)

^d NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^g Tsinghua University   (China)

^h NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP4; VIRUS PROTEIN; CAPSID PROTEIN;

HEPATITIS; HIGH TEMPERATURE; PH; PHYLOGENETICS; VIRUS; X-RAY SPECTROSCOPY;

ARTICLE; HEPATITIS A VIRUS; HIGH TEMPERATURE; INSECT VIRUS; MATURE VIRUS; NONHUMAN; PH; PHYLOGENY; PICORNAVIRIDAE; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSCYTOSIS; VIRUS PARTICLE; X RAY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HEAT; HUMAN; INSECT; MOLECULAR EVOLUTION; VIRION; VIROLOGY; VIRUS CAPSID; VIRUS ENTRY; X RAY CRYSTALLOGRAPHY;

HEPATITIS A VIRUS; HEXAPODA;

ANIMALS; CAPSID; CAPSID PROTEINS; CRYSTALLOGRAPHY, X-RAY; EVOLUTION, MOLECULAR; HEPATITIS A VIRUS; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; INSECTS; MODELS, MOLECULAR; PHYLOGENY; PICORNAVIRIDAE; TRANSCYTOSIS; VIRION; VIRUS INTERNALIZATION;

EID: 84922480678     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13806     Document Type: Article

References (39)

1. WHO. Hepatitis A. Fact Sheet No. 328 http://www.who.int/mediacentre/factsheets/fs328/en/(2013).
2. Feng, Z. et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496, 367-371 (2013).
3. Siegl, G., Weitz, M. & Kronauer, G. Stability of hepatitis A virus. Intervirology 22, 218-226 (1984).
4. Ping, L. H.&Lemon, S. M.Antigenic structure of humanhepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J. Virol. 66, 2208-2216 (1992).
5. Borley, D. W. et al. Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus. PLoS ONE 8, e61122 (2013).
6. Tate, J. et al. The crystal structure of cricket paralysis virus: the first view of a new virus family. Nature Struct. Biol. 6, 765-774 (1999).
7. Squires, G. et al. Structure of the Triatoma virus capsid. Acta Crystallogr. D. 69, 1026-1037 (2013).
8. Dotzauer, A., Brenner, M., Gebhardt, U. & Vallbracht, A. IgA-coated particles of HepatitisAvirus are translocalized antivectorially fromthe apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor. J. Gen. Virol. 86, 2747-2751 (2005).
9. Dotzauer, A. et al. Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J. Virol. 74, 10950-10957 (2000).
10. Deinhardt, F. Prevention of viral hepatitis A: past, present and future. Vaccine 10 (suppl. 1), 10-14 (1992).
11. Lemon, S. M. & Binn, L. N. Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Infect. Immun. 42, 418-420 (1983).
12. Graff, J. et al. Hepatitis A virus capsid protein VP1 has a heterogeneousC terminus. J. Virol. 73, 6015-6023 (1999).
13. Tesar, M., Jia, X. Y., Summers, D. F. & Ehrenfeld, E. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology 194, 616-626 (1993).
14. Martin, A. & Lemon, S. M. Hepatitis A virus: from discovery to vaccines. Hepatology 43, S164-S172 (2006).
15. Kaplan, G. et al. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15, 4282-4296 (1996).
16. Bishop, N. E. & Anderson, D. A. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology 197, 616-623 (1993).
17. Wang, X. et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nature Struct. Mol. Biol. 19, 424-429 (2012).
18. Rossmann, M. G. et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-153 (1985).
19. Siegl, G., Frosner, G. G., Gauss-Muller, V., Tratschin, J. D. & Deinhardt, F. The physicochemical properties of infectious hepatitis A virions. J. Gen. Virol. 57, 331-341 (1981).
20. DeColibus, L. et al. More-powerful virus inhibitors fromstructure-based analysis of HEV71 capsid-binding molecules. Nature Struct. Mol. Biol. 21, 282-288 (2014).
21. Acharya, R. et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9A resolution. Nature 337, 709-716 (1989).
22. Liu, Y.& Eisenberg, D. 3D domain swapping: as domains continue to swap. Protein Sci. 11, 1285-1299 (2002).
23. Walter, T. S. et al. A plate-based high-throughput assay for virus stability and vaccine formulation. J. Virol. Methods 185, 166-170 (2012).
24. Porta, C. et al. Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog. 9, e1003255 (2013).
25. Filman, D. J. et al. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8, 1567-1579 (1989).
26. Warwicker, J.Model for the differential stabilities of rhinovirusandpoliovirustomild acidic pH, based on electrostatics calculations. J. Mol. Biol. 223, 247-257 (1992).
27. Garriga, D. et al. Insights intominor grouprhinovirusuncoating: the X-ray structure of the HRV2 empty capsid. PLoS Pathog. 8, e1002473 (2012).
28. Ren, J. et al. Picornavirus uncoating intermediate captured in atomic detail. Nature Commun. 4, 1929 (2013).
29. Butan, C., Filman, D. J. & Hogle, J. M. Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release. J. Virol. 88, 1758-1770 (2014).
30. Riffel, N. et al. Atomicresolutionstructure ofMoloneymurineleukemia virusmatrix protein and its relationship to other retroviral matrix proteins. Structure 10, 1627-1636 (2002).
31. Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D 61, 651-657 (2005).
32. Minor, W., Cymborowski, M., Otwinowski, Z. & Chruszcz, M. HKL-3000: the integration of data reduction and structure solution-fromdiffraction images to an initial model in minutes. Acta Crystallogr. D 62, 859-866 (2006).
33. Bruger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
34. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486-501 (2010).
35. Stuart, D. I., Levine, M., Muirhead, H. & Stammers, D. K. Crystal structure of cat muscle pyruvate kinase at a resolutionof 2.6 A. J. Mol. Biol. 134,109-142(1979).
36. Py MOL. The Py MOL Molecular Graphics System, Version 1.5.0.4 Schroinger, LLC. (2002).
37. Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606-1619 (2000).
38. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
39. Chapman, M. S. & Rossmann, M. G. Comparison of surface properties of picornaviruses: strategies for hiding the receptor site fromimmune surveillance. Virology 195, 745-756 (1993).